Plain-English translation of NCT07422870 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a registry study — a database collecting information from patients with idiopathic granulomatous mastitis (IGM), a rare inflammatory breast condition. Researchers are gathering medical records and treatment information from both past and current patients to understand how often this condition occurs, what it looks like, how it progresses over time, and what treatments doctors are using. By studying patterns across many patients, researchers hope to develop better treatment guidelines for people diagnosed with this condition in the future.
Idiopathic granulomatous mastitis is a rare condition that doctors don't yet fully understand — the cause is unknown, and there are no evidence-based treatment guidelines. Patients often suffer from repeated breast infections and abscess formation that don't respond well to antibiotics, and doctors may resort to surgery or mastectomy out of desperation. This study exists to collect real-world experience from many patients and doctors across Europe so that researchers can identify which treatments actually work and help future patients avoid unnecessary procedures.
You likely qualify if…
You likely don't qualify if…
If you enroll in the prospective (ongoing) part of this study, researchers will ask you to share your medical records and consent to follow-up information gathering as you receive treatment. If you're included from past medical records (retrospective part), no follow-up is needed — your anonymous historical data will simply be added to the registry. Either way, your identity remains completely private, and the study will track what treatments you receive, how you respond, and how your condition evolves over time.
AI-generated summary from trial data · Sep 18, 2026 · Not medical advice
Germany